Pharmacosmos A/S

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re

After recently raising a Series B funding of $32m from Chinese investors, EOC Pharma is planning to expand its team in clinical development, regulatory affairs and CMC (chemistry, manufacturing, and c

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

The table records clinical and regulatory developments using data from Informa Pharma Intelligence’s Biomedtracker . It lists all drugs for which an event was recorded from Aug. 19 to Aug 25, 2016,